Blog
Communities In Schools And Hudson Celebrate 15-Year Philanthropy Milestone
Communities In Schools And Hudson Celebrate 15-Year Philanthropy Milestone
Form 8.3 - The Vanguard Group, Inc.: Network International Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Network International Holdings plc
EQS-News: Cantourage Group SE sets corporate record: four new cultivation partners within a month
EQS-News: Cantourage Group SE sets corporate record: four new cultivation partners within a month
Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)
Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)
EQS-Adhoc: 029 Group SE: Change in the Administrative Board
EQS-Adhoc: 029 Group SE: Change in the Administrative Board
EQS-News: Shelly Group PLC announces terms of dividend payment
EQS-News: Shelly Group PLC announces terms of dividend payment
EQS-News: Schaeffler AG: Schaeffler opens new development center in Kysuce: Think-tank for tomorrow’s mobility
EQS-News: Schaeffler AG: Schaeffler opens new development center in Kysuce: Think-tank for tomorrow’s mobility
EQS-Adhoc: Result of the 2022 annual audit of Varengold Bank AG still open
EQS-Adhoc: Result of the 2022 annual audit of Varengold Bank AG still open
029 Group SE: Changes in the Administrative Board
029 Group SE: Changes in the Administrative Board
Amundi Asset Management: Securities will be halted
Amundi Asset Management: Securities will be halted
Nordea Bank Abp: Norwegian Systemic Risk Buffer partially reciprocated by Finnish Financial Supervisory Authority and applicable to Nordea from 1 July 2024
Nordea Bank Abp: Norwegian Systemic Risk Buffer partially reciprocated by Finnish Financial Supervisory Authority and applicable to Nordea from 1 July 2024
EQS-Adhoc: Heidelberg Pharma Sells Minority Shareholding in Emergence Therapeutics
EQS-Adhoc: Heidelberg Pharma Sells Minority Shareholding in Emergence Therapeutics
Manz AG wins renowned new customer from the automotive industry and receives order for high-volume assembly line for inverters
Manz AG wins renowned new customer from the automotive industry and receives order for high-volume assembly line for inverters
EQS-News: Annual General Meeting of PVA TePla AG resolves expansion and elects Dr. Myriam Jahn to the Supervisory Board
EQS-News: Annual General Meeting of PVA TePla AG resolves expansion and elects Dr. Myriam Jahn to the Supervisory Board
EQS-News: Mainz Biomed Secures up to $50M in New Funding
EQS-News: Mainz Biomed Secures up to $50M in New Funding
u-blox AG: u-blox introduces its newest dual-band Wi-Fi 6 and dual-mode Bluetooth® 5.3 module
u-blox AG: u-blox introduces its newest dual-band Wi-Fi 6 and dual-mode Bluetooth® 5.3 module
Nordea Bank Abp: Transaction in Own Shares
Nordea Bank Abp: Transaction in Own Shares
Polymetal: Update to the timetable of the Re-domiciliation
Polymetal: Update to the timetable of the Re-domiciliation
Polymetal: Notice of 2023 AGM
Polymetal: Notice of 2023 AGM
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
EQS-News: Carbon footprint reduced significantly: DEMIRE publishes EPRA Sustainability Report for the year 2022
EQS-News: Carbon footprint reduced significantly: DEMIRE publishes EPRA Sustainability Report for the year 2022
EQS-News: Formycon announces submission of the biologics license application (BLA) for FYB203, an aflibercept biosimilar candidate to the U.S. Food and Drug Administration (FDA)
EQS-News: Formycon announces submission of the biologics license application (BLA) for FYB203, an aflibercept biosimilar candidate to the U.S. Food and Drug Administration (FDA)
EQS-News: PharmaSGP Holding SE: Strong support at 2023 AGM for very successful business development
EQS-News: PharmaSGP Holding SE: Strong support at 2023 AGM for very successful business development
EQS-News: APONTIS PHARMA launches Single Pill Finder and distribution of Single Pill Rosazimib - First of three launches in 2023
EQS-News: APONTIS PHARMA launches Single Pill Finder and distribution of Single Pill Rosazimib - First of three launches in 2023
EQS-News: Evotec receives milestone payment for first patient dosed in Phase I study of Bayer kidney disease programme
EQS-News: Evotec receives milestone payment for first patient dosed in Phase I study of Bayer kidney disease programme


